A Portrait of Cord Blood Units Distributed for Transplantation from Canadian Blood Services' Cord Blood Bank: First Analysis.
cord blood banking
ethnicity
hematopoietic
transplantation
Journal
Current oncology (Toronto, Ont.)
ISSN: 1718-7729
Titre abrégé: Curr Oncol
Pays: Switzerland
ID NLM: 9502503
Informations de publication
Date de publication:
06 12 2022
06 12 2022
Historique:
received:
24
10
2022
revised:
23
11
2022
accepted:
02
12
2022
entrez:
22
12
2022
pubmed:
23
12
2022
medline:
27
12
2022
Statut:
epublish
Résumé
The Canadian Blood Services Cord Blood Bank (CBS CBB) was created to improve access to stem cell products for transplantation for patients across ethnic groups. An analysis of distributed units is needed to assess the effectiveness of the bank to meet the needs of patients from different ethnic groups. A descriptive analysis was performed on all cord blood units distributed from the CBS' CBB as of 30 June 2022. Distribution of the first 60 units based on CBS' CBB inventory has been linear over time. A similar proportion of cord blood unit (CBU) recipients were pediatric or adult. More than half of the cord blood units (56.7%) were distributed to recipients outside of Canada, and CBUs were used to treat a broad range of hematologic and immune disorders. 43.3% of distributed CBUs were of non-Caucasian ethnicity and 18% were from donors self-reporting as multi-ethnic. The mean total nucleated cell counts and total CD34 The CBS' CBB has facilitated the utilization of banked units for patients across a broad range of ages, geographic distribution, ethnicity, and diseases. Distributed units were well matched for HLA alleles and contained robust cell counts, reflecting a high-quality inventory with significant utility.
Sections du résumé
BACKGROUND
The Canadian Blood Services Cord Blood Bank (CBS CBB) was created to improve access to stem cell products for transplantation for patients across ethnic groups. An analysis of distributed units is needed to assess the effectiveness of the bank to meet the needs of patients from different ethnic groups.
METHODS
A descriptive analysis was performed on all cord blood units distributed from the CBS' CBB as of 30 June 2022.
RESULTS
Distribution of the first 60 units based on CBS' CBB inventory has been linear over time. A similar proportion of cord blood unit (CBU) recipients were pediatric or adult. More than half of the cord blood units (56.7%) were distributed to recipients outside of Canada, and CBUs were used to treat a broad range of hematologic and immune disorders. 43.3% of distributed CBUs were of non-Caucasian ethnicity and 18% were from donors self-reporting as multi-ethnic. The mean total nucleated cell counts and total CD34
CONCLUSIONS
The CBS' CBB has facilitated the utilization of banked units for patients across a broad range of ages, geographic distribution, ethnicity, and diseases. Distributed units were well matched for HLA alleles and contained robust cell counts, reflecting a high-quality inventory with significant utility.
Identifiants
pubmed: 36547166
pii: curroncol29120752
doi: 10.3390/curroncol29120752
pmc: PMC9777040
doi:
Substances chimiques
HLA Antigens
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
9572-9581Références
PLoS One. 2015 Dec 01;10(12):e0143440
pubmed: 26624279
Br J Haematol. 2016 Feb;172(3):360-70
pubmed: 26577457
Biol Blood Marrow Transplant. 2011 Jan;17(1):78-85
pubmed: 20561593
Haematologica. 2022 May 01;107(5):1045-1053
pubmed: 34382386
Biol Blood Marrow Transplant. 2010 Nov;16(11):1541-8
pubmed: 20800103
Bone Marrow Transplant. 2022 May;57(5):742-752
pubmed: 35194156
Biol Blood Marrow Transplant. 2020 Dec;26(12):2190-2196
pubmed: 32736011
Blood. 2013 May 9;121(19):3981-7
pubmed: 23493783
Biol Blood Marrow Transplant. 2009 Dec;15(12):1634-7
pubmed: 19896088
Bone Marrow Transplant. 2021 Jul;56(7):1651-1664
pubmed: 33623153
N Engl J Med. 2016 Sep 8;375(10):944-53
pubmed: 27602666
Blood. 2012 Mar 22;119(12):2949-55
pubmed: 22308292
Transfusion. 2016 Mar;56(3):662-5
pubmed: 26585667
Transplant Cell Ther. 2022 Feb;28(2):109.e1-109.e8
pubmed: 34775146
Cytotherapy. 2022 Oct;24(10):1060-1066
pubmed: 35654716
Bone Marrow Transplant. 2022 Jun;57(6):1021-1024
pubmed: 35397653
Biol Blood Marrow Transplant. 2020 Jul;26(7):1247-1256
pubmed: 32165328
Transplant Cell Ther. 2022 Nov 15;:
pubmed: 36396108
N Engl J Med. 2014 Jul 24;371(4):339-48
pubmed: 25054717
Blood. 2021 Jan 21;137(3):420-428
pubmed: 33475736
Transfusion. 2019 Jul;59(7):2382-2388
pubmed: 31002398
Biol Blood Marrow Transplant. 2017 Jun;23(6):965-970
pubmed: 28263918